Cargando…
Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
BACKGROUND: Knowledge of pathogenic variants in cancer‐predisposing genes is important when making breast cancer treatment decisions, but genetic testing is not universal and criteria must be met to qualify for genetic testing. The objective of this study was to evaluate the pathogenic variant yield...
Autores principales: | Metcalfe, Kelly A., Narod, Steven A., Eisen, Andrea, Poll, Aletta, Zamani, Neda, McCready, David, Cil, Tulin D., Wright, Frances C., Lerner‐Ellis, Jordan, McCuaig, Jeanna, Graham, Tracy, Sun, Ping, Akbari, Mohammad R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067031/ https://www.ncbi.nlm.nih.gov/pubmed/36544278 http://dx.doi.org/10.1002/cam4.5515 |
Ejemplares similares
-
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
por: McCuaig, Jeanna M., et al.
Publicado: (2022) -
Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer
por: McCuaig, Jeanna M., et al.
Publicado: (2018) -
Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review
por: Boghosian, Talin, et al.
Publicado: (2021) -
A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care
por: McCuaig, Jeanna M., et al.
Publicado: (2021) -
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
por: Care, Melanie, et al.
Publicado: (2020)